NMPA Approval

Compound Paracetamol and Amantadine Hydrochloride Capsules

Approval Number

国药准字H22025791

Company山西千汇药业有限公司

Registration Date

September 21, 2020

Previous Approval Numbers

国药准字H22025791

Drug Information

Generic Name

复方氨酚烷胺胶囊

Dosage Form

胶囊剂

Strength

复方

Drug Type

化学药品

Registration Date

September 21, 2020

Company Information

Applicant Company

Company Name山西千汇药业有限公司

Company Address

山西省太原经济技术开发区生物医药园(唐明路42号）

Manufacturing Company

Company Name上海凯合荣图们药业有限公司

Company Address

吉林省图们市图们大路231号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方氨酚烷胺胶囊 - NMPA 批准文号 | MedPath